Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
1
x
$
30.00
Colorectal Cancer Screening: How Are We Doing and How Can We Improve?
1
x
$
0.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
View Cart
Checkout
Home
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
“Assessment of Anxiety in Clinical Trials with Depressed Patients” has been added to your cart.
View cart
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
$
30.00
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 4 Articles
Tags:
cara-l-alfaro
,
cytochrome-p450
,
drug-development
,
food-and-drug-administration
,
medworks-media
,
new-dru-g-application
,
psychopharmacology-bulletin
,
regulatory-guidance
Description
Description
Cara L. Alfaro, PharmD
DRUG INTERACTIONS
Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
Cara L. Alfaro, PharmD
Related products
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Zonisamide for Bipolar Depression by Deborah Dauphinais
$
30.00
Add to cart
Details
Page load link
Go to Top
